Abstract No. 526 CheckMate-9DX: phase 3, randomized,...

Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation

Exposito, M. Jimenez, Akce, M., Alvarez, J., Assenat, E., Balart, L., Baron, A., Decaens, T., Heurgue-Berlot, A., Martin, A., Paik, S., Poulart, V., Sehbai, A., Shimada, M., Takemura, N., Yoon, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Journal of Vascular and Interventional Radiology
DOI:
10.1016/j.jvir.2018.12.607
Date:
March, 2019
File:
PDF, 71 KB
english, 2019
Conversion to is in progress
Conversion to is failed